Faisal Khurshid
Stock Analyst at Leerink Partners
(0.77)
# 3,739
Out of 4,749 analysts
13
Total ratings
27.27%
Success rate
-12.19%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Faisal Khurshid
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KYMR Kymera Therapeutics | Maintains: Outperform | $60 | $39.59 | +51.55% | 2 | Dec 27, 2024 | |
| ANIP ANI Pharmaceuticals | Initiates: Outperform | $80 | $58.64 | +36.43% | 1 | Dec 11, 2024 | |
| ZURA Zura Bio | Initiates: Outperform | $15 | $1.88 | +697.87% | 1 | Nov 4, 2024 | |
| TRVI Trevi Therapeutics | Assumes: Outperform | $7 | $3.94 | +77.66% | 1 | Sep 9, 2024 | |
| PRTC PureTech Health | Assumes: Outperform | $45 | $19.10 | +135.60% | 1 | Sep 9, 2024 | |
| PLRX Pliant Therapeutics | Assumes: Outperform | $33 | $10.75 | +206.98% | 1 | Sep 9, 2024 | |
| IRWD Ironwood Pharmaceuticals | Initiates: Market Perform | $5 | $2.34 | +113.68% | 1 | Sep 9, 2024 | |
| GLPG Galapagos NV | Initiates: Market Perform | $24 | $23.00 | +4.35% | 1 | Sep 9, 2024 | |
| GERN Geron | Initiates: Outperform | $7 | $2.87 | +143.90% | 1 | Sep 9, 2024 | |
| MNKD MannKind | Assumes: Outperform | $8 | $5.79 | +38.17% | 1 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Outperform | $5 | $0.98 | +412.82% | 1 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $11 | $3.74 | +194.21% | 1 | Mar 21, 2023 |
Kymera Therapeutics
Dec 27, 2024
Maintains: Outperform
Price Target: $60
Current: $39.59
Upside: +51.55%
ANI Pharmaceuticals
Dec 11, 2024
Initiates: Outperform
Price Target: $80
Current: $58.64
Upside: +36.43%
Zura Bio
Nov 4, 2024
Initiates: Outperform
Price Target: $15
Current: $1.88
Upside: +697.87%
Trevi Therapeutics
Sep 9, 2024
Assumes: Outperform
Price Target: $7
Current: $3.94
Upside: +77.66%
PureTech Health
Sep 9, 2024
Assumes: Outperform
Price Target: $45
Current: $19.10
Upside: +135.60%
Pliant Therapeutics
Sep 9, 2024
Assumes: Outperform
Price Target: $33
Current: $10.75
Upside: +206.98%
Ironwood Pharmaceuticals
Sep 9, 2024
Initiates: Market Perform
Price Target: $5
Current: $2.34
Upside: +113.68%
Galapagos NV
Sep 9, 2024
Initiates: Market Perform
Price Target: $24
Current: $23.00
Upside: +4.35%
Geron
Sep 9, 2024
Initiates: Outperform
Price Target: $7
Current: $2.87
Upside: +143.90%
MannKind
Sep 9, 2024
Assumes: Outperform
Price Target: $8
Current: $5.79
Upside: +38.17%
Sep 9, 2024
Assumes: Outperform
Price Target: $5
Current: $0.98
Upside: +412.82%
Mar 21, 2023
Initiates: Outperform
Price Target: $11
Current: $3.74
Upside: +194.21%